Burcon has introduced new pea and canola protein blends for plant-based dairy and meat alternatives. The firm has also announced a joint venture to open a C$65 million production facility to process 20,000 tons of plant protein per year.
Burcon peas and Peazazz, courtesy of Burcon NutraScience Corporation
Burcon NutraScience Corporation (Vancouver, British Columbia) released new pea-protein and canola-protein blends called Nutratein-PS and Nutratein-TZ. Nutratein-PS, a blend of the firm’s proprietary Peazazz pea protein and Supertein canola protein, is ideal for fortifying dairy alternative beverages such as almond milk or formulating beverages with a nutritional value consistent with cow’s milk. Nutratein-TZ, a blend of Burcon’s proprietary Peazac pea protein and Puratein canola protein, is well-suited from the formulation of plant-based meat products, and even has a Protein digestibility-corrected amino acid score (PDCAAS) that exceed that of beef. PDCAAS is the accepted method by FDA, FAO, and WHO for evaluating the nutritional quality of a protein, with the highest possible score of 1.0, which Burcon’s blends achieve.
“Burcon’s novel and proprietary pea and canola proteins have exciting applications in numerous food and beverage products,” said Johann F. Tergesen, Burcon’s president and chief executive officer, in a press release. “The ability to blend Burcon’s unique pea and canola proteins to create nutritionally unparalleled plant protein combinations in our Nutratein product family, while preserving the highly desirable functional properties the proteins naturally possess, will give us a true competitive advantage, marking a key pillar of our leadership strategy in the rapidly growing plant protein market worldwide.”
In addition, Burcon has entered into a joint venture partnership with an investor group to build a new C$65 million pea protein and canola protein commercial production facility in Western Canada. The new facility is planned to initially process approximately 20,000 tons of peas per year starting in mid-2020 to produce Burcon’s Peazazz, Peazac, Supertein, and Puratein proteins. Through the joint venture, Burcon has established a new operating entity called Burcon Functional Foods Corporation, which will own and operate the facility, and has entered into a licensing agreement with Burcon for the production, sale, and distribution of the firm’s pulse proteins.
“Having the capacity to produce both our unique pea proteins, as well as our canola proteins, in our own production facility is a key pillar of our differentiation strategy,” explains Tergeson. “The ability to blend our pea and canola proteins to create nutritionally unparalleled plant protein combinations, while preserving the highly desirable functional properties the proteins naturally possess, will give us a true competitive advantage. We look forward to offering our pea and canola protein products to customers and consumers in Canada, North America and worldwide.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.